Close Menu

Lumora

Lumora's MDx technology for the clinical and industrial sectors will be merged with ERBA Mannheim's IVD testing business in a wide range of market segments.

Roche is buying Lumora's heat elution technology, which enables nucleic acid isolation in minutes, as opposed to hours. 

NEW YORK (GenomeWeb News) – New England Biolabs today announced a manufacturing and supply agreement with molecular diagnostics firm Lumora.

Lumora said this week that it has appointed Hayden Jeffreys to its board of directors.

Scientists from UK-based molecular diagnostics developer Lumora have published a pilot study demonstrating how a new heat elution-based sample prep method can be combined with isothermal amplification and Lumora's bioluminescent assay in real-time (BART) readout technology to qui

Lumora and Promega said this week that they have signed an agreement for the use of Promega's Ultra-Glo luciferase in Lumora's bioluminescent assay in real time, or BART, molecular diagnostics technology.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Lumora today announced a supply agreement with Promega for use of its luciferase in Lumora's Bioluminescent Assay in Real-Time, or BART, technology.

Lumora said this week that it has entered into a license and development agreement with Israel's Biogal Galed Labs ACS to develop a series of veterinary diagnostic tests.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Lumora today announced a licensing deal to develop tests for veterinary diagnostics company Biogal Galed Labs.

A pair of recently published peer-reviewed studies has vetted the performance of a new test based on loop-mediated isothermal amplification, or LAMP, as a tool for the quick and easy diagnosis of malaria in both modernized laboratories and in the field in areas of the world where

Pages

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.